All Type of News
KFDA review supplementation extended to 10 days from 7 days.
The terms for the supplementing the documentations especially on the standards and assay methods will be extended now from 7 days to 10 days, and the postponement of the supplementing terms can be extended twice in th...
Online booking system is available for treatment and consultation
Both patients and medical representatives (MRs) can make their online bookings over the medical institutions using a new system, which has been developed by Medimet Co.
The company said this system enables health p...
Health ministry to cover 10,000 insured medicines only
The government plans to ask the national health insurance to cover only 10,000 conventional drugs by phase to reduce snowballing medication costs.
Earlier, the Ministry of Health and Welfare unveiled a set of measu...
KPMA calls for more rational approach to new drug pricing policy
The so-called positive list system reinforces the government's rash approach to shaping policies, according to the Korea Pharmaceutical Manufacturers Association (KPMA).
The KPMA said the ministry will have to over...
Iressa price issue: a signal for drug price slashing policy?
The price down of Iressa, a lung cancer drug, is now on a hot dispute among the MOHW, the civil health/medical groups and AZ company where is claiming that its price reduction has lack of justification.
AZ won the ...
Early protection essential for decline of cervical cancer
Early detection/prevention efforts will be effective for the prevention of cervical cancer incidence and mortality, according to a local medical professor.
In a recent forum hosted by the Korean Society of Gynecolo...
Oriental graduated medical school to establish in 2008.
The government decided in the relevant ministerial meeting to establish an oriental graduate medical school some time in 2008, for which nobody knows which university it puts in. Originally, the government was about t...
Medium-sized drug makers go for duel with multinational giant
Competition is about to heat up in the Korean antihypertensive market dominated by Pfizer Korea's Norvasc (amlodipine besylate) as a growing number of medium-sized pharmaceutical firms are ready to enter the local mar...
Exports of pharmaceutical bulk products grew 0.29% in first half
Despite increased competition from China and other emerging economies, the nation's first-half outbound shipment for pharmaceutical raw materials edged up 0.29 percent to $235 million for the first time after fi...
Sehwa Pharm names new vice president
Sewha Pharm, a leading wholesaler in Pusan, appointed Lee Eun-bo as its new executive vice president as of August 2, to upgrade the detailing capacity of 30 salespersons to meet the needs of pharmaceutical firms.
T...
